These observations combine to suggest that the loss of multiple regulatory miRs that post-transcriptionally regulate DNMT3b levels is involved in the molecular mechanism governing the DNMT3b-mediated hypermethylation defect in breast cancer cell lines. This evidence concerns the gene DNMT3B and breast carcinoma.